| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/20/2008 | WO2008033931A1 Para-xylylene carboxylic acids and isothiazolones useful as protein tyrosine phosphatases (ptps) in particular ptp-ib |
| 03/20/2008 | WO2008033854A1 Certain substituted amides, method of making, and method of use thereof |
| 03/20/2008 | WO2008033793A2 Synthesis of methyl nonactate derivatives |
| 03/20/2008 | WO2008033567A1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 03/20/2008 | WO2008032171A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
| 03/20/2008 | WO2008005910A3 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 03/20/2008 | WO2007139960A3 Compounds that modulate hsp90 activity and methods for identifying same |
| 03/20/2008 | US20080070972 for an oral cytokine inhibitor of interleukin-1 beta converting enzyme; antiinflammatory agent: rheumatoid arthritis and psoriasis; wet granulated compound with the organic solvent, a first and second binding agent, porous agent, glidant, lubricant |
| 03/20/2008 | US20080070951 Viricides; HIV antivirals effective against problematic drug escape mutants; N-[(1S,1aR,7bR)-4,7-difluoro-1,1a,2,7b-tetrahydrocyclopropa[c]chromen-1-yl]-N'-[5-(4-(sulfonamido)phenoxy)-2-pyridinyl]urea |
| 03/20/2008 | US20080070945 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |
| 03/20/2008 | US20080070916 Treating disorders such as proliferative diseases, and cancer; compounds can act as probes of biological function; libraries; for example, 2-ethoxy-3-(2-hydroxyethoxyethoxyethyl)-4-(1-acetylindol-3-yl)-6-(morpholinocarbonyl)-2H-3,4-dihydropyran |
| 03/20/2008 | US20080070915 Poly(ADP-ribose)polymerase (PARP); ischemia, reperfusion injuries, neurological disorders, neuroprotectants, sensitizer for chemotherapy or radiotherapy, anticancer |
| 03/20/2008 | US20080070906 Quinolinone derivatives |
| 03/20/2008 | US20080070902 Cinnamide Compound |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | DE102007037830A1 Indolinsulfonamidverbindungen Indolinsulfonamidverbindungen |
| 03/20/2008 | CA2663376A1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 03/20/2008 | CA2663189A1 Benzimidazolone derivatives |
| 03/20/2008 | CA2663178A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
| 03/20/2008 | CA2663113A1 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 03/20/2008 | CA2661654A1 Certain substituted amides, method of making, and method of use thereof |
| 03/19/2008 | EP1900732A1 Novel nitrogenated heterocyclic compound and salt thereof |
| 03/19/2008 | EP1899324A2 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| 03/19/2008 | EP1899322A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 03/19/2008 | EP1899299A2 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/19/2008 | EP1898905A2 Hydroisoindoline tachykinin receptor antagonists |
| 03/19/2008 | EP1824338B1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides |
| 03/19/2008 | EP1660487B1 Pyrrole compositions useful as inhibitors of c-met |
| 03/19/2008 | EP1646613B1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1532132B1 Novel benzodioxoles |
| 03/19/2008 | EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 03/19/2008 | EP1458380B1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 03/19/2008 | CN101146799A Cgrp-antagonists, process for their preparation as well as their use as medicaments |
| 03/19/2008 | CN101146798A Novel heterocyclic benzo[C]chromene derivatives useful as modulators of the estrogen receptors |
| 03/19/2008 | CN101146797A 4-2-(cycloalkylamino)pyrimidin-4-YL!- (phenyl)- imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases |
| 03/19/2008 | CN101146786A Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/19/2008 | CN101146769A Azolylacylguanidines as beta-secretase inhibitors |
| 03/19/2008 | CN101146530A 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 03/19/2008 | CN101143864A Novel triazolo pyrimidine compounds |
| 03/18/2008 | US7345175 Biphenyl derivatives |
| 03/18/2008 | US7345090 Galenical formulation |
| 03/18/2008 | US7345085 Indoles having anti-diabetic activity |
| 03/18/2008 | US7345079 Treatment of disorder related to low cyclic GMP levels |
| 03/18/2008 | US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/18/2008 | US7345059 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 03/18/2008 | US7345054 Heterocyclic inhibitors of ERK2 and uses thereof |
| 03/18/2008 | US7345052 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 03/18/2008 | US7345051 For controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infections |
| 03/18/2008 | US7345044 Sodium channel blockers |
| 03/18/2008 | US7344701 For conjugation with biomolecules, drugs, and toxins |
| 03/18/2008 | CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 03/18/2008 | CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators |
| 03/13/2008 | WO2008030448A1 Phenethylamide derivatives with kinase inhibitory activity |
| 03/13/2008 | WO2008029924A1 Cyclic aminoalkylcarboxamide derivative |
| 03/13/2008 | WO2008029876A1 Salt of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1h)-one and crystal thereof |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008029257A2 Improved method for preparing 1,3-disubstituted pyrrolidine compounds |
| 03/13/2008 | WO2008028691A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 03/13/2008 | WO2008028624A1 Fungicides |
| 03/13/2008 | WO2007148185A3 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
| 03/13/2008 | WO2007146376A3 Substituted 3-cyanopyridines as protein kinase inhibitors |
| 03/13/2008 | WO2007136302A8 Active substances, pharmaceutical composition and a method for the production and use thereof |
| 03/13/2008 | WO2007136116A3 C-phenyl glycitol compound for the treatment of diabetes |
| 03/13/2008 | WO2007135527A3 Benzimidazolyl compounds |
| 03/13/2008 | WO2007123939A8 Novel arylamino n-heteraryls as mek inhibitors |
| 03/13/2008 | US20080064873 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents |
| 03/13/2008 | US20080064726 Dipeptidyl peptidase-IV (DPP-IV) inhibitor; diabetes mellitus, insulin-resistant diseases, obesity, hypoglycemia ; 2-[4-({2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl}amino)-4-methylpiperdin-1-yl]-2-oxoethyl acetate monofumarate |
| 03/13/2008 | US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate |
| 03/13/2008 | US20080064706 Piperidine Derivatives as Histamine H3 Receptor Ligands |
| 03/13/2008 | US20080064704 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors |
| 03/13/2008 | US20080064700 Aryl triazines as LPAAT-beta inhibitors and uses thereof |
| 03/13/2008 | US20080064695 Neuronal nicotinic acetylcholine receptor modulators; such as ethyl 1-[4-(aminosulfonyl)phenyl]-5-(4-bromophenyl)-2-methyl-1H-pyrrole-3-carboxylate |
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/13/2008 | US20080064679 Water Soluble Cannabinoids |
| 03/13/2008 | US20080064677 S1P receptor modulating compounds and use thereof |
| 03/13/2008 | US20080064661 Dihydroxyl compounds and compositions for cholesterol management and related uses |
| 03/13/2008 | CA2662839A1 Improved method for preparing 1,3-disubstituted pyrrolidine compounds |
| 03/13/2008 | CA2662281A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 03/13/2008 | CA2662259A1 Fungicides |
| 03/13/2008 | CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators |
| 03/12/2008 | EP1897878A1 Stable crystal of protected pseudouridine |
| 03/12/2008 | EP1896467A2 Tricyclic opioid modulators |
| 03/12/2008 | EP1896460A1 Benzofuranyl derivatives as 5-ht6-receptor inhibitors |
| 03/12/2008 | EP1896459A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 03/12/2008 | EP1896458A1 New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 03/12/2008 | EP1896457A1 New 2-azetidinone derivatives useful in the treatment of hyperlipidaemic conditions |
| 03/12/2008 | EP1896456A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 03/12/2008 | EP1896454A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR -SECRETASE MODULATION |
| 03/12/2008 | EP1896453A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 03/12/2008 | EP1896448A1 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
| 03/12/2008 | EP1896438A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 03/12/2008 | EP1896428A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 03/12/2008 | EP1896422A2 Tyrosine kinase inhibitors |
| 03/12/2008 | EP1896421A2 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 03/12/2008 | EP1896417A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |